The Filing Desk

Healthcare Triangle vs SOPHiA GENETICS

Healthcare Triangle HCTI · SOPHiA GENETICS SOPH · Health Care Technology

SOPHiA GENETICS reported revenue of $77 million in fiscal 2025, 5.6 times Healthcare Triangle's $14 million in fiscal 2025. Healthcare Triangle's revenue grew 18.8% in its latest year, and SOPHiA GENETICS's grew 18.6%. Healthcare Triangle had an operating margin of -70.5%, against -91.8% at SOPHiA GENETICS. Free cash flow was −$17 million at Healthcare Triangle and −$36 million at SOPHiA GENETICS.

Side by side

Healthcare TriangleSOPHiA GENETICS
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$14M$77M
Revenue growth18.8%18.6%
Revenue growth a year, last 5 years−15.0%22.2%
Gross margin—67.4%
Operating margin−70.5%−91.8%
Net margin−68.2%−102.2%
Free cash flow−$17M−$36M
Free cash flow margin−119.0%−47.2%
Return on capital—−207.1%
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count17,427.8%2.2%
Last close$2.95$6.68
P/E at the last close——
Insider trades, last 12 months—bought $99,000, sold $4.2 million
Piotroski F-score—2 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Healthcare TriangleSOPHiA GENETICS
Operating margin
Percent of revenue
Healthcare TriangleSOPHiA GENETICS
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Healthcare TriangleSOPHiA GENETICS

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Healthcare Triangle and SOPHiA GENETICS pages.